Request for Professional Guidance on Reporting Prescriber Names in Medication Error Analysis

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to cmichalek@ismp.org

1 post / 0 new
Mahmoud Abumandil
Mahmoud Abumandil's picture
Offline
Last seen: 6 days 14 hours ago
Joined: 09/17/2021 - 13:14
Request for Professional Guidance on Reporting Prescriber Names in Medication Error Analysis

Dear Medication Safety Officers Society Team,
Greetings.

We would appreciate your professional opinion regarding a medication safety reporting practice currently under discussion within our organization.
As part of prescribing error analysis, there has been a request to provide the names of prescribers associated with medication errors, together with the number and types of prescribing errors identified. While the objective is to support patient safety improvement and trend analysis, there are concerns regarding maintaining a Just Culture approach and ensuring that reporting systems remain focused on learning, system improvement, and prevention rather than perceived individual blame.

We would be grateful for your guidance on the following:
Is it considered a best practice to routinely report individual prescribers' names as part of medication error trend reporting?
What do recognized medication safety and Just Culture principles recommend regarding the disclosure of prescriber identities in safety reports?
Should practitioner-specific reporting, when required, be managed through Quality, Risk Management, Credentialing, or another governance structure rather than by the reporting pharmacy team?
Are there any published guidelines, standards, or position statements that address this matter?
We value your expertise and would greatly appreciate any references, recommendations, or experiences that could help guide our approach while maintaining a strong patient safety culture.

Thank you for your support and guidance.

Kind regards,
Mahmoud